Efficacy of L-Arginine, Myoinositol, and Chromium with Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome: A Randomized Comparative Study

Abd El-Aziz NG, Osama H, Salem SAM, Rabea HM

Published August 10, 2026 Endocrine research, 1-12
DOI 10.1080/07435800.2026.2713536 PMID 42573014

RRM Academy Synopsis

Letrozole plus myoinositol or chromium improved ovulation in PCOS

Letrozole plus chromium or myoinositol improved ovulation and insulin resistance in a randomized trial of 240 women with polycystic ovary syndrome (PCOS) and infertility. The women formed four groups of 60. Myoinositol had the highest pregnancy rates in the first two months.

Key Findings

  • Pregnancy was most frequent with myoinositol: 36.7% after one month and 41.9% after two months.
  • Testosterone fell significantly in the chromium, myoinositol, and L-arginine groups.
  • Weight, hirsutism, and the homeostatic model assessment of insulin resistance (HOMA-IR) decreased in the chromium and myoinositol groups (p = 0.001).
  • Ovulation rates differed among the groups at 1 month (p = 0.026), at 2 months (p = 0.039), and at 3 months (p = 0.008).

Interpretation

The trial was prospective and randomized. Three arms paired letrozole with chromium, L-arginine, or myoinositol, and one arm was a control. The authors tracked ovulation, insulin resistance, testosterone, dehydroepiandrosterone (DHEA), and hirsutism before and after treatment. Letrozole with chromium or myoinositol improved PCOS ovulation, HOMA-IR, and hirsutism, they concluded. The synopsis draws on the published abstract.

RRM Context

Restorative reproductive medicine looks for the root cause of poor ovulation. PCOS now has a new name, polyendocrine metabolic ovarian syndrome (PMOS). The trial measured ovulation and insulin resistance together. It also measured androgens and pregnancy rates.

Abstract

Background

PCOS is a hormonal disorder with no medication, hence treatment is symptomatic. Letrozole plus chromium, L-arginine, or myoinositol was tested in PCOS-infertile women.

Methods

This prospective trial randomly assigned 240 PCOS patients (n = 60) to one of four groups: letrozole + chromium, L-arginine, myoinositol, or the control. Insulin resistance, testosterone, HOMA-IR, hirsutism, DHEA, and ovulatory function were examined before and after treatment.

Results

At each follow-up, all groups showed substantially different ovulation rates (p = 0.026, 0.039, and 0.008 at 1, 2, and 3 months, respectively). Weight, HOMA-IR, and hirsutism were decreased with chromium and myoinositol (p = 0.001). Chromium, myoinositol, and L-arginine significantly reduced testosterone. Myoinositol had the highest pregnancy rates at one and two months (36.7% and 41.9%, respectively).

Conclusion

letrozole combined with chromium or myoinositol improves PCOS ovulation, HOMA-IR, and hirsutism.

By this author

Related research

Nehal G Abd El-Aziz, Hasnaa Osama, Sara Abdallah Mohamed Salem, Hoda M Rabea
N El-Aziz, H Osama, S Salem, H Rabea
PMID 42573014 42573014 DOI 10.1080/07435800.2026.2713536 10.1080/07435800.2026.2713536 Abd El-Aziz et al. 2026, Abd El-Aziz 2026